<!DOCTYPE html>
<html>
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8"/>
	<title></title>
	<meta name="generator" content="LibreOffice 7.3.1.3 (Linux)"/>
	<meta name="created" content="2023-10-26T20:27:08.823352696"/>
	<meta name="changed" content="2023-11-14T11:57:23.435003274"/>
	<style type="text/css">
		@page { size: 8.5in 11in; margin: 0.79in }
		p { line-height: 115%; margin-bottom: 0.1in; background: transparent; background: transparent }
		h1 { margin-bottom: 0.08in; background: transparent; background: transparent; page-break-after: avoid }
		h1.western { font-family: "Liberation Serif", serif; font-size: 24pt; font-weight: bold }
		h1.cjk { font-family: "Noto Serif CJK SC"; font-size: 24pt; font-weight: bold }
		h1.ctl { font-family: "Lohit Devanagari"; font-size: 24pt; font-weight: bold }
		h4 { margin-top: 0.08in; margin-bottom: 0.08in; background: transparent; background: transparent; page-break-after: avoid }
		h4.western { font-family: "Liberation Serif", serif; font-size: 12pt; font-weight: bold }
		h4.cjk { font-family: "Noto Serif CJK SC"; font-size: 12pt; font-weight: bold }
		h4.ctl { font-family: "Lohit Devanagari"; font-size: 12pt; font-weight: bold }
		h5 { margin-top: 0.08in; margin-bottom: 0.04in; background: transparent; background: transparent; page-break-after: avoid }
		h5.western { font-family: "Liberation Serif", serif; font-size: 10pt; font-weight: bold }
		h5.cjk { font-family: "Noto Serif CJK SC"; font-size: 10pt; font-weight: bold }
		h5.ctl { font-family: "Lohit Devanagari"; font-size: 10pt; font-weight: bold }
		strong { font-weight: bold }
		a:link { color: #000080; so-language: zxx; text-decoration: underline }
		a:visited { color: #800000; so-language: zxx; text-decoration: underline }
	</style>
</head>
<body lang="en-US" link="#000080" vlink="#800000" dir="ltr"><h1 class="western" style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2; margin-top: 0in; margin-bottom: 0in">
<font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt">ACC/AHA
Guidelines for the Management of Patients With Unstable Angina and
Non–ST-Segment Elevation Myocardial Infarction: Executive Summary
and Recommendations</font></font></font></h1>
<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>

</p>
<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2; margin-bottom: 0in">
<font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt">A
Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Committee on the
Management of Patients With Unstable Angina)</font></font></font></p>
<p style="font-weight: normal; orphans: 2; widows: 2; margin-bottom: 0in">
<br/>

</p>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><i><span style="font-weight: normal">Class
I: Conditions for which there is evidence and/or general agreement
that a given procedure or treatment is useful and effective</span></i></span></font></font></font></span></strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">.</span></span></span></font></font></font></span></p>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><i><span style="font-weight: normal">Class
II: Conditions for which there is conflicting evidence and/or a
divergence of opinion about the usefulness/efficacy of a procedure or
treatment.</span></i></span></font></font></font></span></strong></p>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><i><span style="font-weight: normal">Class
IIa: Weight of evidence/opinion is in favor of usefulness/efficacy.</span></i></span></font></font></font></span></strong></p>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><i><span style="font-weight: normal">Class
IIb: Usefulness/efficacy is less well established by
evidence/opinion.</span></i></span></font></font></font></span></strong></p>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><i><span style="font-weight: normal">Class
III: Conditions for which there is evidence and/or general agreement
that the procedure/treatment is not useful/effective and in some
cases may be harmful.</span></i></span></font></font></font></span></strong></p>
<hr/>

<h4 class="western" style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2; margin-top: 0in; margin-bottom: 0in"><a name="d1e437"></a>
<font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt">A.
Clinical Assessment</font></font></font></h4>
<h5 class="western" style="font-weight: normal; orphans: 2; widows: 2; margin-top: 0in; margin-bottom: 0in">
<br/>

</h5>
<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">1.
Patients with symptoms that suggest possible ACS should not be
evaluated solely over the telephone but should be referred to a
facility that allows evaluation by a physician and the recording of a
12-lead electrocardiogram (ECG). </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">2.
Patients with a suspected ACS with chest discomfort at rest for &gt;20
minutes, hemodynamic instability, or recent syncope or presyncope
should be strongly considered for immediate referral to an emergency
department (ED) or a specialized chest pain unit. Other patients with
a suspected ACS may be seen initially in an ED, a chest pain unit, or
an outpatient facility. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2">
<font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt">B.
Early Risk Stratification</font></font></font></p>
<h5 class="western" style="font-weight: normal; orphans: 2; widows: 2; margin-top: 0in; margin-bottom: 0in">
<br/>

</h5>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">1.
A determination of the likelihood (high, intermediate, or low) of
acute ischemia caused by CAD should be made in all patients with
chest discomfort. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">2.
Patients who present with chest discomfort should undergo early risk
stratification that focuses on anginal symptoms, physical findings,
ECG findings, and biomarkers of cardiac injury. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: B</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">3.
A 12-lead ECG should be obtained immediately (within 10 minutes) in
patients with ongoing chest discomfort and as rapidly as possible in
patients who have a history of chest discomfort consistent with ACS
but whose discomfort has resolved by the time of evaluation. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">4.
Biomarkers of cardiac injury should be measured in all patients who
present with chest discomfort consistent with ACS. A cardiac-specific
troponin is the preferred marker, and if available, it should be
measured in all patients. CK-MB by mass assay is also acceptable. In
patients with negative cardiac markers within 6 hours of the onset of
pain, another sample should be drawn in the 6- to 12-hour time frame
(eg, at 9 hours after the onset of symptoms). </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
I, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">1.
For patients who present within 6 hours of the onset of symptoms, an
early marker of cardiac injury (eg, myoglobin or CK-MB subforms)
should be considered in addition to a cardiac troponin. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
IIa, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">1.
C-reactive protein(CRP) and other markers of inflammation should be
measured. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
IIb, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: B</span></span></span></font></font></font></span></strong></p>
<hr/>

<p style="orphans: 2; widows: 2"><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">1.
Total CK (without MB), aspartate aminotransferase (AST,
SGOT),β-hydroxybutyric dehydrogenase, and/or lactate dehydrogenase
should be the marker for the detection of myocardial injury in
patients with chest discomfort suggestive of ACS. </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeueBoldCondensed, HelveticaNeue-Bold-Condensed, Helvetica Neue Bold Condensed, HelveticaNeue-CondensedBold, HelveticaNeueBold, HelveticaNeue-Bold, Helvetica Neue Bold, HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosCnBold, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Class
III, </span></span></span></font></font></font></span></strong><strong><span style="font-variant: normal"><font color="#000000"><font face="HelveticaNeue, Helvetica Neue, HelveticaNeueRoman, HelveticaNeue-Roman, Helvetica Neue Roman, TeXGyreHerosRegular, Helvetica, Arial, serif"><font size="2" style="font-size: 9pt"><span style="letter-spacing: normal"><span style="font-style: normal"><span style="font-weight: normal">Level
of Evidence: C</span></span></span></font></font></font></span></strong></p>
</body>
</html>